Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-011904
Filing Date
2024-08-12
Accepted
2024-08-12 16:30:28
Documents
69
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q agrx-20240630x10q.htm   iXBRL 10-Q 1435902
2 EX-31.1 agrx-20240630xex31d1.htm EX-31.1 10623
3 EX-31.2 agrx-20240630xex31d2.htm EX-31.2 10565
4 EX-32.1 agrx-20240630xex32d1.htm EX-32.1 5937
5 EX-32.2 agrx-20240630xex32d2.htm EX-32.2 5903
  Complete submission text file 0001558370-24-011904.txt   6046739

Data Files

Seq Description Document Type Size
6 EX-101.SCH agrx-20240630.xsd EX-101.SCH 50084
7 EX-101.CAL agrx-20240630_cal.xml EX-101.CAL 41103
8 EX-101.DEF agrx-20240630_def.xml EX-101.DEF 194322
9 EX-101.LAB agrx-20240630_lab.xml EX-101.LAB 404205
10 EX-101.PRE agrx-20240630_pre.xml EX-101.PRE 302486
72 EXTRACTED XBRL INSTANCE DOCUMENT agrx-20240630x10q_htm.xml XML 853416
Mailing Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635
Business Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635 609-683-1880
AGILE THERAPEUTICS INC (Filer) CIK: 0001261249 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36464 | Film No.: 241197199
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)